289 Results

People

  1. Kelsen
    Kelsen
  2. Bajorin
    Bajorin
  3. Bosl
    Bosl
  4. Motzer
    Motzer
  5. Lichtman
    Lichtman
  6. Ilson
    Ilson
  7. Heelan
    Heelan
  8. Jaimes
    Jaimes
  9. De Angelis
    De Angelis
  10. Herr
    Herr

Groups

  1. Department of Medicine (140)
  2. Solid Tumor Oncology Division (91)
  3. Surgery (60)
  4. Survivorship Research (48)
  5. Division of Subspecialty Medicine (38)
  6. Genitourinary Oncology Service (34)
  7. Center for Pancreatic Cancer Research (32)
  8. Gastrointestinal Oncology Service (30)
  9. Hematologic Malignancies, Division of (28)
  10. Center for Hematologic Malignancies (26)
  1. "nephrotoxicity"
Formats
  1. Journal Article (263)
  2. Review (12)
  3. Conference Paper (6)
  4. Book Section (3)
  5. Guidelines (2)
  6. Editorial (1)
  7. Miscellaneous (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (140)
  2. Solid Tumor Oncology Division (91)
  3. Surgery (60)
  4. Survivorship Research (48)
  5. Division of Subspecialty Medicine (38)
  6. Genitourinary Oncology Service (34)

More Groups

People
  1. David Kelsen (24)
  2. George Bosl (19)
  3. Dean Bajorin (17)
  4. Robert Motzer (14)
  5. Stuart Lichtman (13)
  6. David Ilson (11)

More People

Years
  1. 2025 (4)
  2. 2024 (7)
  3. 2023 (1)
  4. 2022 (9)
  5. 2021 (2)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (30)
  2. Cancer (20)
  3. Cancer Treatment Reports (10)
  4. Gynecologic Oncology (9)
  5. Seminars in Oncology (8)
  6. Pediatric Blood and Cancer (7)

More Publications

Publishers
  1. Elsevier Inc. (53)
  2. American Society of Clinical Oncology (31)
  3. Wiley Blackwell (25)
  4. Oxford University Press (21)
  5. Lippincott Williams & Wilkins (14)
  6. Elsevier Science, Inc. (11)

More Publishers

Results (289)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus
    Journal Article

    Minsky, B. D.; Neuberg, D.; Kelsen, D. P.; Pisansky, T. M.; Ginsberg, R. J.; Pajak, T.; Salter, M.; Benson, A. B. 3rd
    International Journal of Radiation Oncology, Biology, Physics (1999)

    Fulltext@MSK | Save
  • Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis
    Journal Article

    Wingard, J. R.; Kubilis, P.; Lee, L.; Yee, G.; White, M.; Walshe, L.; Bowden, R.; Anaissie, E.; Hiemenz, J.; Lister, J.
    Clinical Infectious Diseases (1999)

    Fulltext@MSK | Save
  • Phase I study of topotecan administered as a 21-day continuous infusion in children with recurrent solid tumors: A report from the Children's Cancer Group
    Journal Article

    Frangoul, H.; Ames, M. M.; Mosher, R. B.; Reid, J. M.; Krailo, M. D.; Seibel, N. L.; Shaw, D. W. W.; Steinherz, P. G.; Whitlock, J. A.; Holcenberg, J. S.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Irinotecan and cisplatin in upper gastrointestinal malignancies
    Conference Paper

    Enzinger, P. C.; Ilson, D. H.; Saltz, L. B.; O'Reilly, E. M.; Kelsen, D. P.
    C M P Medica LLC * The Oncology Group (1998)

    Fulltext@MSK | Save
  • A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia
    Journal Article

    Weiss, M. A.; Drullinsky, P.; Maslak, P.; Scheinberg, D.; Golde, D. W.
    Leukemia (1998)

    Fulltext@MSK | Save
  • Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus
    Journal Article

    Ilson, D. H.; Ajani, J.; Bhalla, K.; Forastiere, A.; Huang, Y.; Patel, P.; Martin, L.; Donegan, J.; Pazdur, R.; Reed, C.; more...
    Journal of Clinical Oncology (1998)

    Fulltext@MSK | Save
  • Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia
    Journal Article

    White, M. H.; Bowden, R. A.; Sandler, E. S.; Graham, M. L.; Noskin, G. A.; Wingard, J. R.; Goldman, M.; Van Burik, J. A.; McCabe, A.; Lin, J. S.; more...
    Clinical Infectious Diseases (1998)

    Fulltext@MSK | Save
  • Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: Improved canner therapy administered to a nude mouse model in relation to the internal radiation dosimetry
    Conference Paper

    Behr, T. M.; Sharkey, R. M.; Sgouros, G.; Blumenthal, R. D.; Dunn, R. M.; Kolbert, K.; Griffiths, G. L.; Siegel, J. A.; Becker, W. S.; Goldenberg, D. M.
    Wiley Blackwell (1997)

    Fulltext@MSK | Save
  • Toxicity of chemotherapy for esophageal carcinoma
    Journal Article

    Ilson, D.
    Chest Surgery Clinics of North America (1997)

    Fulltext@MSK | Save
  • A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: A preliminary report
    Journal Article

    Kelsen, D.; Ginsberg, R.; Bains, M.; Cooper, J.; Arquette, M.; Forastiere, A. A.; Ilson, D.
    Seminars in Oncology (1997)

    Fulltext@MSK | Save